Private equity giant Blackstone is said to be nearing a deal to buy pharmaceuticals and regulatory consulting business Advarra from Genstar Capital at $5bn valuation.
The post Blackstone near deal to buy Advarra from Genstar at $5bn valuation – report first appeared on AltAssets Private Equity News.
